TY - JOUR
T1 - Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer
AU - Jereczek-Fossa, Barbara Alicja
AU - Cattani, Federica
AU - Garibaldi, Cristina
AU - Zerini, Dario
AU - Cambria, Raffaella
AU - Boboc, Genoveva Ionela
AU - Valenti, Marco
AU - Kowalczyk, Anna
AU - Vavassori, Andrea
AU - Ivaldi, Giovanni Battista
AU - Ciocca, Mario
AU - Matei, Deliu Victor
AU - De Cobelli, Ottavio
AU - Orecchia, Roberto
PY - 2007/11
Y1 - 2007/11
N2 - Purpose: To evaluate the feasibility and accuracy of daily B-mode acquisition and targeting ultrasound-based prostate localization (BAT™) and to compare it with computed tomography (CT) and electronic portal imaging (EPI) in 3-dimensional conformal radiotherapy (3-D CRT) for prostate cancer. Patients and Methods: Ten patients were treated with 3-D CRT (72 Gy/30 fractions, 2.4 Gy/fraction, equivalent to 80 Gy/40 fractions, for α/β ratio of 1.5 Gy) and daily BAT-based prostate localization. For the first 5 fractions, CT and EPI were also performed in order to compare organ-motion and set-up error, respectively. Results: 287 BAT-, 50 CT- and 46 EPI-alignments were performed. The average BAT-determined misalignments in latero-lateral, antero-posterior and cranio-caudal directions were -0.9 mm ± 3.3 mm, 1.0 mm ± 4.0 mm and -0.9 mm ± 3.8 mm, respectively. The differences between BAT- and CT-determined organ-motion in latero-lateral, antero-posterior and cranio-caudal directions were 2.7 mm ± 1.9 mm, 3.9 ± 2.8 mm and 3.4 ± 3.0 mm, respectively. Weak correlation was found between BAT- and CT-determined misalignments in antero-posterior direction, while no correlation was observed in latero-lateral and cranio-caudal directions. The correlation was more significant when only data of good image-quality patients were analyzed (8 patients). Conclusion: BAT ensures the relative positions of target are the same during treatment and in treatment plan, however, the reliability of alignment is patient-dependent. The average BAT-determined misalignments were small, confirming the prevalence of random errors in 3-D CRT. Further study is warranted in order to establish the clinical value of BAT.
AB - Purpose: To evaluate the feasibility and accuracy of daily B-mode acquisition and targeting ultrasound-based prostate localization (BAT™) and to compare it with computed tomography (CT) and electronic portal imaging (EPI) in 3-dimensional conformal radiotherapy (3-D CRT) for prostate cancer. Patients and Methods: Ten patients were treated with 3-D CRT (72 Gy/30 fractions, 2.4 Gy/fraction, equivalent to 80 Gy/40 fractions, for α/β ratio of 1.5 Gy) and daily BAT-based prostate localization. For the first 5 fractions, CT and EPI were also performed in order to compare organ-motion and set-up error, respectively. Results: 287 BAT-, 50 CT- and 46 EPI-alignments were performed. The average BAT-determined misalignments in latero-lateral, antero-posterior and cranio-caudal directions were -0.9 mm ± 3.3 mm, 1.0 mm ± 4.0 mm and -0.9 mm ± 3.8 mm, respectively. The differences between BAT- and CT-determined organ-motion in latero-lateral, antero-posterior and cranio-caudal directions were 2.7 mm ± 1.9 mm, 3.9 ± 2.8 mm and 3.4 ± 3.0 mm, respectively. Weak correlation was found between BAT- and CT-determined misalignments in antero-posterior direction, while no correlation was observed in latero-lateral and cranio-caudal directions. The correlation was more significant when only data of good image-quality patients were analyzed (8 patients). Conclusion: BAT ensures the relative positions of target are the same during treatment and in treatment plan, however, the reliability of alignment is patient-dependent. The average BAT-determined misalignments were small, confirming the prevalence of random errors in 3-D CRT. Further study is warranted in order to establish the clinical value of BAT.
KW - 3-D conformal radiotherapy
KW - Computed Tomography
KW - Electronic portal imaging
KW - Prostate cancer
KW - Ultrasonography
UR - http://www.scopus.com/inward/record.url?scp=36248976981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36248976981&partnerID=8YFLogxK
U2 - 10.1007/s00066-007-1702-5
DO - 10.1007/s00066-007-1702-5
M3 - Article
C2 - 17960336
AN - SCOPUS:36248976981
VL - 183
SP - 610
EP - 616
JO - Strahlentherapie und Onkologie
JF - Strahlentherapie und Onkologie
SN - 0179-7158
IS - 11
ER -